Emerging perspectives in epidermal growt
β
Seungwon Kim; Jennifer R. Grandis; Alessandra Rinaldo; Robert P. Takes; Alfio Fe
π
Article
π
2008
π
John Wiley and Sons
π
English
β 109 KB
π 1 views
## Abstract The epidermal growth factor receptor (EGFR) has been shown to be a promising therapeutic target in head and neck cancer. Cetuximab, a monoclonal antibody against EGFR, has been approved in the United States for use with radiotherapy for head and neck squamous cell carcinoma. However, th